Cargando…
Administration and Burden of Subcutaneous Immunotherapy for Allergic Rhinitis in U.S. and Canadian Clinical Practice
BACKGROUND: Allergy immunotherapy (AIT) is the only available treatment that alters the natural course of allergies and has possible disease-modifying effects. AIT is administered primarily via subcutaneous injection delivered in a physician’s office. Few studies have been conducted in the United St...
Autores principales: | Blume, Steven W., Yeomans, Karen, Allen-Ramey, Felicia, Smith, Nancy, Kim, Harold, Lockey, Richard F., Nichol, Michael B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397750/ https://www.ncbi.nlm.nih.gov/pubmed/26521110 http://dx.doi.org/10.18553/jmcp.2015.21.11.982 |
Ejemplares similares
-
Administration and burden of subcutaneous immunotherapy for allergic rhinitis in clinical practice in Canada
por: Blume, Steven W, et al.
Publicado: (2014) -
Subcutaneous Immunotherapy Improves the Symptomatology of Allergic Rhinitis
por: Lourenço, Edmir Américo, et al.
Publicado: (2015) -
Safety of specific subcutaneous immunotherapy in patients with allergic rhinitis
por: Da Fonseca, Mario Henrique Almeida, et al.
Publicado: (2015) -
Efficacy and Safety of Subcutaneous Allergen Immunotherapy for Allergic Rhinitis
por: Sohn, Myung Hyun
Publicado: (2018) -
Allergy immunotherapy prescribing trends for grass pollen-induced allergic rhinitis in Germany: a retrospective cohort analysis
por: McDonell, Amanda L., et al.
Publicado: (2015)